Endoscopic Evaluation Advised in Non-Hodgkin's Lymphoma

This article originally appeared here.
Share this content:
Endoscopic Evaluation Advised in Non-Hodgkin's Lymphoma
Endoscopic Evaluation Advised in Non-Hodgkin's Lymphoma

TUESDAY, Sept. 1, 2015 (HealthDay News) -- For elderly adults diagnosed with non-Hodgkin's lymphoma, endoscopic evaluation may be recommended even in the absence of gastrointestinal symptoms, according to a letter to the editor published in the August issue of the Journal of the American Geriatrics Society.

Sebahat Basyigit, M.D., from the Kecioren Research and Training Hospital in Ankara, Turkey, and colleagues describe a case of diffuse large B-cell lymphoma (DLBCL) in an 87-year-old man admitted to the emergency department complaining of fatigue and chronic constipation.

The researchers note that the patient had no significant medical or family history. His physical examination was generally normal except for palpable cervical, axillary, and inguinal lymph nodes. Hemoglobin was 13.8 g/dL, white blood count 16,600/µL, and erythrocyte sedimentation rate 50 mm/L per hour. A conglomerated lymphadenopathy 3 cm in diameter was seen on abdominal computed tomography near the mesenteric artery. According to histopathological examination of the axillary lymph node, the patient was diagnosed with DLBCL. Based on chronic constipation and mesenteric lymph node enlargement, the patient underwent rectosigmoidoscopy. Multiple white-bellied nodules were identified in the rectosigmoid junction; findings from histopathologic examination of colonic biopsy specimens were consistent with mantle cell lymphoma.

"Endoscopic evaluation may be recommended in elderly adults diagnosed with non-Hodgkin lymphoma even if they do not have severe gastrointestinal complaints," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »